Monthly Archives: August 2016

Xiidra (Lifitegrast), a new prescription eye drop for dry eye, approved by the FDA

For the first time in over 10 years (since Restasis), a treatment for dry eye has been approved by the FDA. The approval happened in July: According to the company, in all four studies, a larger reduction in eye dryness

Posted in Patient Care, Treatment Tagged with: ,

Stem cell advancements signal a possible cure for Sjogren’s Syndrome

Once again, current news compels me to refer to my January post, Hope for 2016 – 5 upcoming treatments for Sjogren’s Syndrome. In that post, my #1 treatment was stem cells. I mentioned that there are two types of stem cell

Posted in Research, Treatment Tagged with:

Abatacept open-label study for Sjogren’s Syndrome concludes with promising results.

Back in January, I wrote a post titled Hope for 2016 – 5 upcoming treatments for Sjogren’s Syndrome, I mentioned an active clinical trial using Orencia/Abatacept to treat Sjogren’s Syndrome. That trial is still ongoing, but a smaller Japanese trial for

Posted in Uncategorized
WordPress Appliance - Powered by TurnKey Linux